COMMUNIQUÉS West-GlobeNewswire

DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026
03/06/2026
Châtillon, France, le 3 juin 2026 DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026 Toutes les résolutions proposées à l’Assemblée Générale ont été adoptées DBV Technologies (Euronext [...]
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
03/06/2026
NOVATO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany
03/06/2026
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. [...]
Monthly information on share capital and company voting rights
03/06/2026
PARIS, June 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 05/31/2026 100,691,658 106,134,467 For further [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. All of the draft resolutions on the 2026 AGM [...]
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
04/06/2026
Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok’s Short-Term Campaign Risks Disrupting Seer’s Momentum and Undermines Stockholder [...]
DBV Technologies Announces the Results of its 2026 Combined General Meeting
03/06/2026
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
04/06/2026
CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the recent opening of study A5413, a study that expands upon the [...]
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
03/06/2026
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today [...]
Celularity Releases CEO Letter to Shareholders
03/06/2026
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
REYKJAVÍK, Iceland and LUXEMBOURG, June 03, 2026 (GLOBE NEWSWIRE) -- The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, [...]
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
03/06/2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mai 2026
03/06/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mai 2026 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’Assemblée
03/06/2026
NANTES, France, le 3 juin 2026, 20h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) (la « Société ») , annonce la tenue de son Assemblée Générale Mixte le 24 juin 2026 à 10h00 dans les locaux du [...]
Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting
03/06/2026
NANTES, France, June 3, 2026 – 8:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company") , announced that it will hold its Annual General Meeting on June 24, 2026, at 10:00 am CET at Jones [...]
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025
03/06/2026
OSE Immunotherapeutics publie ses résultats financiers consolidés audités pour l’exercice 2025 et annonce le dépôt de son Document d’Enregistrement Universel 2025 Les résultats financiers consolidés audités 2025 sont en [...]
OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document
03/06/2026
2025 Audited financial statements are consistent with Unaudited financial statements previously reported on April 30, 2026 The IRIS Financing announced on May 28, 2026, was added as a subsequent event Confirmed cash [...]
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
03/06/2026
VALNEVA Declaration of shares and voting rights Status as of May 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint- [...]
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 31 mai 2026
03/06/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 31 mai 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social [...]

Pages